SSI News - 2023

2023

• Development of the candidate tuberculosis vaccine H56:IC31 ended

  19 December 2023
  Vaccine Well Tolerated and Demonstrated Immunogenicity But Did Not Provide Protection Against TB Recurrence. Participants Being Informed; Further Analysis Continues

  ---

• Researchers have discovered a new bacterial species

  21 November 2023
  Researchers from Statens Serum Institut have discovered a new bacterial species that can cause excruciating hand infections.

  ---

• English webpage for the national wastewater surveillance of SARS-CoV-2

  9 November 2023
  The webpage for the national wastewater surveillance of SARS-CoV-2 is now available in English. On this webpage, it is possible to find results and download data from the surveillance.

  ---

• New research sheds light on genetics of placenta growth

  6 October 2023
  Study identifies 40 variations in the genetic code linked to placenta growth and points at link to health risks for mother and child.

  ---

• Description og the first cases of SARS-CoV-2 variant BA.2.86 from Denmark published

  11 September 2023
  BA.2.86 is a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged recently at global level. When a new variant of a pandemic pathogen emerges, quick initial assessment and sharing of information are of high importa...

  ---

• Three cases of BA.2.86 have been detected in Denmark

  18 August 2023
  Statens Serum Institut has detected another case of the new subvariant of omicron, B.2.86.

  ---

• Increased sick leave over a long period after covid-19 infection

  19 April 2023
  A survey from Statens Serum Institut showed that people who were infected with SARS-CoV-2 early on during the pandemic took substantially more sick leave over a long period of time compared to those who were not infected.

  ---

• The year that passed: A busy year for infectious disease preparedness

  24 January 2023
  The first EPI-NEWS of the year describes infectious disease outbreaks in 2022.

  ---